n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine has been researched along with Bone Marrow Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blazsek, I; Bourut, C; Chenu, E; Lemaigre, G; Maral, R; Mathé, G; Mauvernay, Y; Schally, AV | 1 |
1 other study(ies) available for n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine and Bone Marrow Diseases
Article | Year |
---|---|
Experimental protection by a luteinizing hormone-releasing hormone agonist of a bone marrow nitrosourea aplasia. Preliminary observations.
Topics: Animals; Body Weight; Bone Marrow; Bone Marrow Diseases; Double-Blind Method; Gonadotropin-Releasing Hormone; Hematopoietic Stem Cells; Luteolytic Agents; Male; Mice; Nitrosourea Compounds; Triptorelin Pamoate | 1984 |